2022
DOI: 10.1039/d2an00218c
|View full text |Cite
|
Sign up to set email alerts
|

A portable blood lactate sensor with a non-immobilized enzyme for early sepsis diagnosis

Abstract: Early determination of blood lactate levels may accelerate the detection of sepsis, one of the most time-sensitive illnesses.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…LOx was used for HRPF benchmarking due to its large size (167 kDa tetramer assembly) and our interests in wearable lactate biosensors for tracking hypoxia in airmen, fatigue monitoring in sports and sepsis in critical care. [33][34][35][36][37][38] "Inoperando" protein footprinting experiments with clinical human samples can help in rational optimization of LOx constructs and sensor design for wearable lactate biosensor development. However, the •OH in HRPF readily react with components of human samples, like glucose, leading to undesirable secondary radical reactions and reduction of the total •OH concentration available for labeling reaction with the LOx enzyme.…”
Section: Methionine Amidementioning
confidence: 99%
“…LOx was used for HRPF benchmarking due to its large size (167 kDa tetramer assembly) and our interests in wearable lactate biosensors for tracking hypoxia in airmen, fatigue monitoring in sports and sepsis in critical care. [33][34][35][36][37][38] "Inoperando" protein footprinting experiments with clinical human samples can help in rational optimization of LOx constructs and sensor design for wearable lactate biosensor development. However, the •OH in HRPF readily react with components of human samples, like glucose, leading to undesirable secondary radical reactions and reduction of the total •OH concentration available for labeling reaction with the LOx enzyme.…”
Section: Methionine Amidementioning
confidence: 99%
“…We have benchmarked the •OH labeling of FOX against a synchrotron XFP beamline using lactate oxidase (LOx) as a model protein system. LOx was used for HRPF benchmarking due to its large size (167 kDa tetramer assembly) and our interests in wearable lactate biosensors for tracking hypoxia in airmen, fatigue monitoring in sports, and sepsis in critical care. “ In operando ” protein footprinting experiments with clinical samples can help in the rational optimization of LOx constructs and sensor design for wearable lactate biosensor development. However, the •OH in HRPF on clinical samples may readily react with components of human plasma, like vital proteins (such as albumin) and metabolites (such as sugars and fats), leading to undesirable secondary radical reactions and reduction of the total •OH concentration available for the labeling reaction of the LOx enzyme .…”
Section: Introductionmentioning
confidence: 99%
“…In addition, ABG can also cause a high-risk infection when the blood sample is frequently collected from an artery [ 10 ]. To overcome these issues, electrochemical biosensors are being explored due to their high sensitivity, selectivity, simplicity, rapid response, cost-effectiveness, lack of requirement for sample preparation, and the considerable ease in developing a portable device for point-of-care (POC) diagnosis [ 11 , 12 , 13 ].…”
Section: Introductionmentioning
confidence: 99%